Bodo Junge - Concepedia

Author

Bodo Junge

Also Known As

B Junge, B. JUNGE, B. Junge, BODO JUNGE, Bodo Junge

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Bodo Junge is an author at Bayer (Germany) specializing in medicine, drug discovery, and pharmacology.

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	557
2	Biochemistry	3	3	510
3	Pharmacology	3	3	84
4	Natural Sciences	2	2	37
5	Biomolecular Engineering	2	2	495

Bodo Junge

Publications

Citations

H-Index

Page 1

	Year	Citations
Chemistry and Biochemistry of Microbial α‐Glucosidase Inhibitors Ernst Truscheit, Werner Frommer, Bodo Junge, Angewandte Chemie International Edition in English Metabolic PathwaysMicrobial α‐Glucosidase InhibitorsAbstract α‐GlucosidasesBiochemistryGlucose Unit	1981	473
?-Glucosidase inhibitors Delf Schmidt, Wolf B. Frommer, Bodo Junge, Die Naturwissenschaften	1977	468
In vitro pharmacology of BAY X1005, a new inhibitor of leukotriene synthesis R. Fruchtmann, Klaus Mohrs, Armin Hatzelmann, Inflammation Research Molecular PharmacologyBay X1005MedicineNew InhibitorPharmacotherapy	1993	47
Reaction of 1‐α‐Cyano‐1‐deoxynojirimycin with Grignard Compounds—Complete Exchange of the CN— Group Horst Böshagen, Walter Geiger, Bodo Junge Angewandte Chemie International Edition in English Medicinal Chemistry1-Deoxynojirimycin DerivativesBioorganic ChemistryEnantioselective SynthesisBiochemistry	1981	22
BAY X1005, a new selective inhibitor of leukotriene synthesis: pharmacology and pharmacokinetics. R. Müller‐Peddinghaus, R. Fruchtmann, H J Ahr, PubMed Bay X1005Lipid PeroxidationNew Selective InhibitorPharmacotherapyWhole Blood	1993	15

Page 1